(ERYP) – FDA
-
ERYTECH (ERYP) No Longer Seeking Approval for Graspa in ALL
-
ERYTECH (ERYP) Reports Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ERYP Stock Lookup